We provide you with 20 years of free, institutional-grade data for CBLI stock, allowing you to gain comprehensive visibility into the fundamentals of the company. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of CBLI. Explore the full financial landscape of CBLI stock.
| Reported Date | CIK | Ticker | Type |
|---|
Cleveland BioLabs, Inc(NASDAQ:CBLI) 
Cleveland BioLabs, Inc., a biopharmaceutical company, develops novel approaches to activate the immune system and address various medical needs in the United States and Russia. Its proprietary platform of toll-like immune receptor activators (TLR) has applications in mitigation of radiation injury, ...
Website: http://www.cbiolabs.com
Full Time Employees: 2 (May 2021)
Sector: Healthcare
Industry: Biotechnology
The information provided in this report about CBLI stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.